RecruitingNCT06026735

Non-small Cell Lung Cancer With Central Nervous System Metastasis

Comprehensive Profiling of Promising Biomarkers in Exosomes From Non-small Cell Lung Cancer With Central Nervous System Metastasis


Sponsor

National Taiwan University Hospital

Enrollment

30 participants

Start Date

Jan 13, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.


Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tissue and fluid samples from patients with non-small cell lung cancer (NSCLC) that has spread to the brain or the lining around the brain (meningeal metastases). These samples are collected during brain surgeries or procedures to better understand how lung cancer behaves when it reaches the central nervous system. **You may be eligible if...** - You have non-small cell lung cancer that has spread to the brain or the fluid around the brain, confirmed by CT or MRI scans - You are scheduled for brain surgery such as tumor removal, drainage procedures, or a shunt placement **You may NOT be eligible if...** - You have non-small cell lung cancer without brain or meningeal spread - Your physical condition makes surgery unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERlung cancer with brain /leptomeningeal metastasis

Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06026735